Stocks to buy

When you go shopping, there is a fine distinction between things that you need and things that are merely nice to have. The consumer discretionary sector falls in the second group — non-essential yet desirable things that people spend money on when extra cash is available. Unlike consumer staples companies, consumer discretionary stocks usually thrive

The macro picture looks extraordinarily bright for electric vehicle charging infrastructure company ChargePoint (NYSE:CHPT), even if some of the sheen has been taken off CHPT stock this year. Source: David Tonelson / Shutterstock.com The company’s strong second-quarter earnings report was largely overlooked. After an initial post-earnings pop, CHPT stock is down more than 10% since

FuelCell (NASDAQ:FCEL) stock, which was once trading at a high of $29, trade at something closer to $6 today. Source: Kaca Skokanova/Shutterstock The company may not be as popular as other clean energy plays, but the shift toward clean energy makes FCEL stock a compelling opportunity at these prices. The shift towards clean energy will

It seemed natural for shares of Chinese electric vehicle maker Nio (NYSE:NIO) to correct after surging from $2.11 in March 2020 to a high just below $67 in January — a gain of more than 3,000% in less than 10 months. Additionally, factors like the chip shortage and regulatory headwinds in China negatively impacted investor

nThe search for the holy grail of lithium battery design is going remarkably well for QuantumScape (NYSE:QS), though QS stock hasn’t made any significant moves as a result. Source: Michael Vi / Shutterstock.com Its recently-released investor presentation showed promising results in its solid-state battery technology. QuantumScape is currently the front-runner in commercializing solid-state batteries and is

They call it FUD: fear, uncertainty and doubt. Based in China, ride-hailing giant Didi Global (NYSE:DIDI) has its fair share of problems, I’ll admit. But there’s also plenty of FUD surrounding DIDI stock. Source: Piotr Swat / Shutterstock.com For example, reports recently circulated claiming that China’s Beijing city government advised state-owned companies to invest in the

It’s definitely fair to say that New York-based Lemonade (NYSE:LMND) is on a mission. If you’re on board with the idea of using AI technology to disrupt insurance as we know it, then a position in LMND stock might be right for you. Source: Stephanie L Sanchez / Shutterstock.com Just to give you a refresher, Lemonade

ViacomCBS (NASDAQ:VIAC) has been a costly disappointment for some investors in 2021. Enthusiasm over the company’s newly-announced streaming plans paired with Reddit-fueled retail investors drove VIAC stock past $100 three weeks into March. That was a 174% gain in under four months. Source: Jer123 / Shutterstock.com A catastrophic crash then saw shares lose half their

Hyliion Holdings (NYSE:HYLN) has been a painful investment for many. A year ago, it shares were was trading as high as $55 a piece. Yet its been downhill ever since. I cautioned in March that a HYLN stock investment would require patience. Source: Hyliion media The stock is down nearly 50% since that call. Despite

Here’s a rare opportunity for you. A “next-generation Medicare Advantage insurer,” Clover Health (NASDAQ:CLOV) operates in a high-potential market, providing health care access to seniors and other patient demographics. Yet, CLOV stock is trading at a surprisingly low price. Source: Shutterstock Currently, this stock has landed gently at a strong support level. So, it might be

In reviewing the opportunity in Roku (NASDAQ:ROKU) stock, I need to start with an apology. A few years ago, I harshly judged it for its delay in reaching profitability. I had good reason at the time, since after 16 years they were still losing money. Management has most definitely shut me up, though, and that’s

Dutch Bros (NYSE:BROS) went public on Sept. 14 at $23.00 per share and immediately spiked to $43.32 as of Sept. 30. That is a gain of more than 88.3% and has led some to argue that BROS stock is overvalued. Source: Alexander Oganezov / Shutterstock.com I looked at some of the numbers in the initial public

On Sept. 24, Carnival (NYSE:CCL) reported that voyages for its fiscal third quarter turned free cash flow (FCF) positive. Of course, this does not mean that the company is profitable yet. But Carnival is now clearly on track. As a result, things look very bright for CCL stock moving forward. Source: Ruth Peterkin / Shutterstock.com

The market has experienced increased volatility over the last few weeks. Investors are still nervous about COVID and inflation, plus new issues including the debt ceiling debate and a possibility of an Evergrande default in China. At times like these, investors may look to lower their risk profile.  One way to do that is to

Ever since Palantir (NYSE:PLTR) stock went public via a direct listing, the company’s contracts with the federal government have been part of the bearish narrative.   Source: Ascannio / Shutterstock.com In the United States, we’ve just marked the anniversary of the terrorist attacks of September 11, 2001. This tragic event was the beginning of a “War on

The coronavirus pandemic disrupted many businesses and was a boon to others. One sector that’s been riding high is the pharmaceutical industry. That’s especially true for companies that have brought a Covid-19 vaccine to market. Vaccine developer Novavax (NASDAQ:NVAX) is a perfect example. NVAX stock rose from relative obscurity with a share price of just

I’m an owner of BlackBerry (NYSE:BB) stock, but I’m willing to admit that I was disappointed by elements of the company’s Sept. 22 second-quarter report. BB stock is down 7.5% this week. Source: Shutterstock Specifically, the year-over-year stagnation of the company’s cybersecurity revenue and its failure to close its long-awaited patent sale were difficult for

Nvidia’s (NASDAQ:NVDA) core businesses have been firing on all cylinders, and its move into other profitable verticals has resulted in consistent top-line growth.  The company’s market value has grown at an incredible pace over the past decade. Yet, NVDA stock still has a ton of upside left with new catalysts that will amplify growth in

Markets are teaching a tough lesson to investors who held onto the belief that Alibaba Group (NYSE:BABA) would stop falling. BABA stock closed at around $145 recently, the lowest level in three years. Source: zhu difeng / Shutterstock.com That Alibaba is half the price from yearly highs would not justify the stock being on sale.

Biotech stocks are infamously one of the most volatile sectors in the stock market. Investors often venture into speculative companies with no proven pipelines. Emerging firms with a pipeline of drugs and products still in the clinical phase post little to no revenue. They raise cash by tapping capital markets to pay for research and